Prothena (PRTA) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

PRTA Prothena

Watchlist

14.430
+0.030+0.21%

Trading Nov 21 11:00 ET

776.46MMarket Cap-5865P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top Premarket Decliners
MT NewswiresNov 19 07:39 ET
Prothena Corp Analyst Ratings
BenzingaNov 13 09:39 ET · Ratings
RBC Capital Maintains Prothena(PRTA.US) With Hold Rating, Maintains Target Price $24
Moomoo NewsNov 13 07:35 ET · Ratings
H.C. Wainwright Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $84
Moomoo NewsNov 13 06:36 ET · Ratings
Prothena's Strategic Advancements and Financial Strength Underpin Buy Rating
TipRanksNov 13 00:55 ET · Ratings
Express News | Prothena Corporation PLC: Expect FY2024 Net Cash Used in Operating & Investing Actives to Be $148 to $160 Mln
ReutersNov 12 16:38 ET

Comments

Moomoo AI

Jan 31 05:38

Investors may miss opportunities or face setbacks if there's no rational basis for the P/S ratio. The moderate P/S ratio suggests investors anticipate a slowdown in revenue. Many investors, less bearish than analysts, hold onto their stocks, risking future disappointment if P/S aligns with growth outlook.

What Prothena Corporation Plc's (NASDAQ:PRTA) P/S Is Not Telling You

Moomoo AI

Nov 28, 2023 05:12

Analysts are forecasting that Prothena will reach break-even point before it might exhaust its cash runway. Given its impressive revenue growth and reduction in cash burn, Prothena appears well positioned to fund further growth with minimal shareholder dilution or borrowing.

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Moomoo AI

Oct 30, 2023 07:14

Despite recent declines, the company's strong growth signals a potential investment opportunity. Market response to its revenue growth indicates interest despite lack of profits.

Prothena (NASDAQ:PRTA) Shareholders Are Still up 224% Over 3 Years Despite Pulling Back 15% in the Past Week

Moomoo AI

Oct 9, 2023 08:34

Overvaluation risk looms for Prothena's shares with high P/S ratio amid poor revenue and weak growth forecast. Investors may face disappointment if the share price realigns with the firm's bleak future outlook.

Prothena Corporation Plc's (NASDAQ:PRTA) Price Is Out Of Tune With Revenues